emtricitabine - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle
AUST R: 326237
Active ingredients:
emtricitabine
tenofovir disoproxil succinate

Dosage form:
Tablet, film coated

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
03 Nov 2023
to
14 Oct 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic brands are available.

TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle
AUST R: 265834
Active ingredients:
emtricitabine
tenofovir disoproxil maleate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
13 Feb 2024
to
10 Apr 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic brands are available.

TENOFOVIR EMT GH tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets
AUST R: 269196
Active ingredients:
emtricitabine
tenofovir disoproxil phosphate

Dosage form:
Tablet, film coated

Sponsor:
Lupin Australia Pty Limited

Phone:
03 9809 7900

Deletion from market:
01 Apr 2024

Shortage status:
To be discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability